-
Kenya's economy faces climate change risks: World Bank
-
Carney scraps Canada EV sales mandate
-
Record January window for transfers despite drop in spending
-
Mining giant Rio Tinto abandons Glencore merger bid
-
Davos forum opens probe into CEO Brende's Epstein links
-
ECB warns of stronger euro impact, holds rates
-
Greece aims to cut queues at ancient sites with new portal
-
ECB holds interest rates as strong euro causes jitters
-
What does Iran want from talks with the US?
-
Wind turbine maker Vestas sees record revenue in 2025
-
Bitcoin under $70,000 for first time since Trump's election
-
Germany claws back 59 mn euros from Amazon over price controls
-
Germany claws back 70 mn euros from Amazon over price controls
-
Stock markets drop amid tech concerns before rate calls
-
BBVA posts record profit after failed Sabadell takeover
-
UN human rights agency in 'survival mode': chief
-
Greenpeace slams fossel fuel sponsors for Winter Olympics
-
Russia says thwarted smuggling of giant meteorite to UK
-
Heathrow still Europe's busiest airport, but Istanbul gaining fast
-
Shell profits climb despite falling oil prices
-
German factory orders rise at fastest rate in 2 years in December
-
Trump fuels EU push to cut cord with US tech
-
Top US news anchor pleads with kidnappers for mom's life
-
The coming end of ISS, symbol of an era of global cooperation
-
New crew set to launch for ISS after medical evacuation
-
Stocks in retreat as traders reconsider tech investment
-
Fiji football legend returns home to captain first pro club
-
Barry Manilow cancels Las Vegas shows but 'doing great' post-surgery
-
Rising euro, falling inflation in focus at ECB meeting
-
AI to track icebergs adrift at sea in boon for science
-
Google's annual revenue tops $400 bn for first time, AI investments rise
-
Boxer Khelif reveals 'hormone treatments' before Paris Olympics
-
BHP damages trial over Brazil mine disaster to open in 2027
-
Bezos-led Washington Post announces 'painful' job cuts
-
UK PM says Mandelson 'lied' about Epstein relations
-
Trump suggests 'softer touch' needed on immigration
-
Panama hits back after China warns of 'heavy price' in ports row
-
US seeks minerals trade zone in rare Trump move with allies
-
US removing 700 immigration officers from Minnesota
-
Son of Norway's crown princess admits excesses but denies rape
-
Netflix film probes conviction of UK baby killer nurse
-
Sales warning slams Ozempic maker Novo Nordisk's stock
-
GSK boosted by specialty drugs, end to Zantac fallout
-
UK's ex-prince leaves Windsor home amid Epstein storm: reports
-
Stocks swing following latest AI-fuelled sell-off on Wall St
-
Whack-a-mole: US academic fights to purge his AI deepfakes
-
UBS grilled on Capitol Hill over Nazi-era probe
-
NASA Moon mission launch delayed to March after test
-
EU must be 'less naive' in COP climate talks: French ministry
-
Air India inspects Boeing 787 fuel switches after grounding
| RBGPF | 0.12% | 82.5 | $ | |
| SCS | 0.12% | 16.14 | $ | |
| CMSC | -0.04% | 23.51 | $ | |
| BCC | -2.57% | 87.97 | $ | |
| RYCEF | -0.36% | 16.62 | $ | |
| RIO | -4.96% | 91.925 | $ | |
| NGG | -1.04% | 86.885 | $ | |
| GSK | 3.45% | 59.275 | $ | |
| BCE | -3.62% | 25.42 | $ | |
| BTI | 0.48% | 61.925 | $ | |
| RELX | 1.16% | 30.13 | $ | |
| AZN | 0.24% | 187.895 | $ | |
| VOD | -7.42% | 14.625 | $ | |
| JRI | -0.38% | 13.1 | $ | |
| CMSD | 0% | 23.87 | $ | |
| BP | -3.04% | 38.045 | $ |
Resilient US economy spurs on stock markets
Upbeat company earnings and healthy US data buoyed stock markets on Friday, pushing ongoing concerns about President Donald Trump's tariffs into the background.
New York -- whose S&P 500 and Nasdaq Composite struck record highs on Thursday -- held on to gains, even if the Dow struggled a little at the start.
Most European and Asian markets were pulled higher as well.
Only Tokyo faltered, dragged down ahead of weekend upper-house elections that could spell trouble for Prime Minister Shigeru Ishiba.
"The positive tone to risk sentiment is continuing on Friday, after a week of record highs for global equities," said Kathleen Brooks, research director at the XTB trading group.
Caution over high valuations was being put aside, for now, as were worries about Trump's threats of further tariffs if governments did not agree trade deals by August 1.
"With the president toning down his rhetoric, markets are quick to forget tariff risks and concentrate on the positives including a resilient US economy," Brooks said.
The overall optimism was fuelled by data suggesting the US economy was doing well, including healthy retail activity and above-forecast results from America's biggest banks.
A June consumer price index report released this week "does not reveal tariff-induced price increases, but a closer look shows clear signs" they could be building, said Holger Schmieding, chief economist at Berenberg bank.
"We expect (US) annual core inflation to approach 3.5 percent by year-end and the Fed to hold the policy rate at the 4.25-4.50 percent target range," he said.
The dollar retreated on Friday as traders bet on the Federal Reserve cutting US interest rates.
One Federal Reserve governor, Christopher Waller, on Thursday argued for a July rate cut, saying he saw limited upside inflation risks.
Trump this week denied he was planning to sack Fed boss Jerome Powell, whom he had been urging to reduce US borrowing costs to further boost the world's top economy.
A meeting in South Africa of G20 finance ministers -- including US representation -- on Friday pointedly stressed that "central bank independence is crucial" around the world.
In corporate news, American Express followed financial sector peers in reporting better-than-expected second-quarter results.
Results from streaming giant Netflix also outperformed, though its share price slipped on Friday as investors weighed its valuation.
In London, British luxury brand Burberry said sales had not fallen as much as analysts expected, "which is a sign that the company’s new strategic direction could be working", said XTB's Brooks.
On the downside, shares in GlaxoSmithKline slid more after the British pharmaceutical giant reported a US regulatory setback for its blood cancer drug Blenrep.
Oil prices rose, supported by fresh EU sanctions aimed at crimping Russia's crude exports to pressure Moscow over its war on Ukraine.
- Key figures at around 1345 GMT -
New York - Dow: DOWN 0.1 percent at 44,441.23 points
New York - S&P 500: UP 0.2 percent at 6,309.96
New York - Nasdaq Composite: UP 0.3 percent at 20,952.31
London - FTSE 100: FLAT at 8,975.89
Paris - CAC 40: UP 0.1 percent at 7,828.93
Frankfurt - DAX: DOWN 0.2 percent at 24,323.11
Tokyo - Nikkei 225: DOWN 0.2 percent at 39,819.11 (close)
Hong Kong - Hang Seng Index: UP 1.3 percent at 24,825.66 (close)
Shanghai - Composite: UP 0.5 percent at 3,534.48 (close)
Euro/dollar: UP at $1.1667 from $1.1600 on Thursday
Pound/dollar: UP at $1.3465 from $1.3415
Dollar/yen: DOWN at 148.25 yen from 148.60 yen
Euro/pound: UP at 86.63 pence from 86.43 pence
Brent North Sea Crude: UP 0.9 percent at $70.15 per barrel
West Texas Intermediate: UP 1.0 percent at $66.88 per barrel
burs/rmb/jhb
M.P.Jacobs--CPN